𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Double-blind donepezil–placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: A pilot study

✍ Scribed by S. Craig Risch; Michael D. Horner; Susan R. McGurk; Simmy Palecko; John S. Markowitz; Ziad Nahas; C. Lindsay DeVane

Book ID
119363010
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
140 KB
Volume
93
Category
Article
ISSN
0920-9964

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Donepezil augmentation of clozapine mono
Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study
✍ Rafael Stryjer; Rael Strous; Faina Bar; Ginette Shaked; Roni Shiloh; Silvio Roze 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

## Abstract Increasing evidence suggests that the cholinergic system is involved in the pathogenesis of schizophrenia. Donepezil, a central cholinesterase inhibitor, improves psychotic symptomatology in demented patients, however, evidence for its role in the management of active psychosis in schiz

Randomized double-blind placebo-controll
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study
✍ Gregory H. Pelton; Oliver L. Harper; Matthias H. Tabert; Harold A. Sackeim; Niko 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

## Abstract ## Objective To assess combined antidepressant and cognitive enhancer treatment in elderly patients presenting with depression plus cognitive impairment. ## Methods Twenty‐three elderly (>50 years old) depressed, cognitively impaired (DEP‐CI) patients participated in a pilot study. W